These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 27012595)

  • 1. Challenges of metabolomics in human gut microbiota research.
    Smirnov KS; Maier TV; Walker A; Heinzmann SS; Forcisi S; Martinez I; Walter J; Schmitt-Kopplin P
    Int J Med Microbiol; 2016 Aug; 306(5):266-279. PubMed ID: 27012595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolome analysis for investigating host-gut microbiota interactions.
    Chen MX; Wang SY; Kuo CH; Tsai IL
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
    Luan H; Wang X; Cai Z
    Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.
    Xie G; Zhang S; Zheng X; Jia W
    Electrophoresis; 2013 Oct; 34(19):2787-98. PubMed ID: 23775228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Yu M; Jia H; Zhou C; Yang Y; Zhao Y; Yang M; Zou Z
    J Pharm Biomed Anal; 2017 May; 138():231-239. PubMed ID: 28219800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities.
    Yen S; McDonald JA; Schroeter K; Oliphant K; Sokolenko S; Blondeel EJ; Allen-Vercoe E; Aucoin MG
    J Proteome Res; 2015 Mar; 14(3):1472-82. PubMed ID: 25670064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches.
    Fiori J; Turroni S; Candela M; Gotti R
    J Pharm Biomed Anal; 2020 Jan; 177():112867. PubMed ID: 31614303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry.
    Zeng Y; Lin Y; Li L; Li Y; Zhang X; Wang M; Chen Y; Luo L; Lu B; Xie Z; Liao Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():133-143. PubMed ID: 30807966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample treatment optimization for fish stool metabolomics.
    Hano T; Ito M; Ito K; Uchida M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():258-267. PubMed ID: 29913338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.
    Liu S; Si C; Yu Y; Zhao G; Chen L; Zhao Y; Zhang Z; Li H; Chen Y; Min L; Zhang S; Zhu S
    Front Cell Infect Microbiol; 2019; 9():178. PubMed ID: 31192167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Brunkwall L; Orho-Melander M
    Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces.
    Behr C; Ramírez-Hincapié S; Cameron HJ; Strauss V; Walk T; Herold M; Beekmann K; Rietjens IMCM; van Ravenzwaay B
    Toxicol Lett; 2018 Oct; 296():139-151. PubMed ID: 30102961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
    Tan AH; Chong CW; Lim SY; Yap IKS; Teh CSJ; Loke MF; Song SL; Tan JY; Ang BH; Tan YQ; Kho MT; Bowman J; Mahadeva S; Yong HS; Lang AE
    Ann Neurol; 2021 Mar; 89(3):546-559. PubMed ID: 33274480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of metabolomics of defined in vitro gut microbial ecosystems.
    Wissenbach DK; Oliphant K; Rolle-Kampczyk U; Yen S; Höke H; Baumann S; Haange SB; Verdu EF; Allen-Vercoe E; von Bergen M
    Int J Med Microbiol; 2016 Aug; 306(5):280-289. PubMed ID: 27020116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health.
    Vernocchi P; Del Chierico F; Putignani L
    Front Microbiol; 2016; 7():1144. PubMed ID: 27507964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foodomics as part of the host-microbiota-exposome interplay.
    Putignani L; Dallapiccola B
    J Proteomics; 2016 Sep; 147():3-20. PubMed ID: 27130534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotyping of gut microbiota: Focus on capillary electrophoresis.
    Ferrer M; Raczkowska BA; Martínez-Martínez M; Barbas C; Rojo D
    Electrophoresis; 2017 Sep; 38(18):2275-2286. PubMed ID: 28605027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
    Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
    Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.